|
Volumn 162, Issue 1, 2015, Pages 16-17
|
From Prescription to Transcription: Genome Sequence as Drug Target
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ROSIGLITAZONE;
ANTIDIABETIC AGENT;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
ALLELE;
BINDING SITE;
CHROMATIN STRUCTURE;
DNA BINDING;
GENE REPRESSION;
GENE SEQUENCE;
GENETIC TRANSCRIPTION;
GENETIC VARIABILITY;
GENOME;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PATIENT IDENTIFICATION;
PERSONALIZED MEDICINE;
PHENOTYPE;
PRESCRIPTION;
PRIORITY JOURNAL;
PROTEIN STRUCTURE;
REVIEW;
TREATMENT RESPONSE;
ANIMAL;
GENETICS;
METABOLISM;
SINGLE NUCLEOTIDE POLYMORPHISM;
ANIMALS;
HUMANS;
HYPOGLYCEMIC AGENTS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
PPAR GAMMA;
|
EID: 84934274102
PISSN: 00928674
EISSN: 10974172
Source Type: Journal
DOI: 10.1016/j.cell.2015.06.033 Document Type: Short Survey |
Times cited : (6)
|
References (10)
|